Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. BIOSCIENCE's NEUTREXIN WILL BE AVAILABLE FOR PCP IN JANUARY

Executive Summary

U.S. BIOSCIENCE's NEUTREXIN WILL BE AVAILABLE FOR PCP IN JANUARY at an average wholesale price of $41.65 per 25 mg vial, for an average cost of about $2,600 for a 21-day course of therapy. The AWP price places the daily cost of the methotrexate analog in the same range as other products in the therapeutic category, U.S. Bioscience maintains. The company also said it is establishing indigent patient programs under which NeuTrexin will be made available free of charge.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS023849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel